Neuroscience 2009-02-18

Modulation of AMPA currents by D(1)-like but not D(2)-like receptors in spinal motoneurons.

P Han, P J Whelan

Index: Neuroscience 158(4) , 1699-707, (2009)

Full Text: HTML

Abstract

Dopamine can modulate and excite spinal locomotor networks, affect afferent transmission and increase motoneuronal excitability. One of the mechanisms whereby dopamine increases motoneuronal excitability is to potentiate AMPA channel-mediated glutamatergic transmission onto motoneurons. However, it is not known which dopaminergic receptor subtypes or the intracellular mechanisms contribute to these effects. In this study, we used whole-cell patch clamp techniques to record chemically evoked AMPA currents in neonatal mouse motoneurons. Bath application of D(1)-like receptor agonist (SKF 39383) increased the AMPA current amplitude and prolonged the decay time constant. In the presence of D(1) receptor antagonist LE300, the effects of DA on AMPA currents were blocked. In contrast, bath-application of the D(2)-like receptor agonist quinpirole did not modulate AMPA currents. In the presence of D(2) receptor antagonist L-741626, dopaminergic modulation of AMPA currents was unaffected. These results suggest that augmentation of AMPA transmission by dopamine is accomplished by D(1) receptor-based mechanisms. This short-term modulation does not appear to involve cycling of AMPA receptor into the membrane, since blocking insertion with botulinum toxin C did not affect the augmentation of AMPA currents after activating D(1) receptors. On the other hand, blocking protein kinase A (PKA) with H-89 completely abolished the effects of D(1) agonists. In addition, we used cell-attached single channel recording to demonstrate that stimulating D(1) receptors increased individual AMPA channel open probability and open duration. Our data demonstrate that dopamine increases the efficacy of glutamatergic transmission onto motoneurons by increasing AMPA conductances via a D(1) PKA-based signaling system.


Related Compounds

  • L-741,626

Related Articles:

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.

2014-02-28

[Oncotarget 5(4) , 882-93, (2014)]

3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.

1996-05-10

[J. Med. Chem. 39 , 1941, (1996)]

The role of the dopamine D2 receptor in descending control of pain induced by motor cortex stimulation in the neuropathic rat.

2012-11-01

[Brain Res. Bull. 89(3-4) , 133-43, (2012)]

Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.

2011-10-01

[Pharmacol. Biochem. Behav. 99(4) , 634-8, (2011)]

Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina.

2003-06-01

[Neuropharmacology 44(8) , 1038-46, (2003)]

More Articles...